UiPath Inc. (NYSE:PATH) CFO Ashim Gupta Sells 10,000 Shares
UiPath Inc. (NYSE:PATH) CFO Ashim Gupta Sells 10,000 Shares
UiPath Inc. (NYSE:PATH – Get Rating) CFO Ashim Gupta sold 10,000 shares of UiPath stock in a transaction that occurred on Monday, December 5th. The stock was sold at an average price of $13.50, for a total value of $135,000.00. Following the transaction, the chief financial officer now directly owns 1,515,341 shares in the company, valued at approximately $20,457,103.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Ashim Gupta also recently made the following trade(s):
Get UiPath alerts:- On Tuesday, November 1st, Ashim Gupta sold 10,000 shares of UiPath stock. The stock was sold at an average price of $12.48, for a total value of $124,800.00.
- On Monday, October 3rd, Ashim Gupta sold 10,000 shares of UiPath stock. The shares were sold at an average price of $12.69, for a total value of $126,900.00.
- On Monday, September 12th, Ashim Gupta sold 30,000 shares of UiPath stock. The shares were sold at an average price of $15.02, for a total value of $450,600.00.
- On Thursday, September 8th, Ashim Gupta sold 10,000 shares of UiPath stock. The shares were sold at an average price of $13.74, for a total value of $137,400.00.
UiPath Trading Up 1.0 %
PATH opened at $12.56 on Thursday. The business's fifty day moving average is $12.27 and its two-hundred day moving average is $16.03. UiPath Inc. has a one year low of $10.40 and a one year high of $48.68.
UiPath (NYSE:PATH – Get Rating) last posted its earnings results on Thursday, December 1st. The healthcare company reported ($0.09) EPS for the quarter, topping analysts' consensus estimates of ($0.18) by $0.09. UiPath had a negative return on equity of 17.19% and a negative net margin of 34.99%. The company had revenue of $262.74 million for the quarter, compared to the consensus estimate of $248.07 million. Analysts forecast that UiPath Inc. will post -0.55 earnings per share for the current fiscal year.Institutional Trading of UiPath
Institutional investors and hedge funds have recently made changes to their positions in the stock. Dynamic Advisor Solutions LLC purchased a new stake in shares of UiPath in the second quarter valued at $212,000. Treasurer of the State of North Carolina purchased a new stake in shares of UiPath in the second quarter valued at $2,871,000. Alps Advisors Inc. purchased a new stake in shares of UiPath in the second quarter valued at $2,145,000. FDx Advisors Inc. lifted its position in shares of UiPath by 21.8% in the second quarter. FDx Advisors Inc. now owns 21,910 shares of the healthcare company's stock valued at $399,000 after acquiring an additional 3,924 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. AG purchased a new stake in shares of UiPath in the second quarter valued at $226,000. 51.35% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on PATH shares. Morgan Stanley lowered UiPath from an "overweight" rating to an "equal weight" rating and dropped their target price for the company from $32.00 to $15.00 in a report on Wednesday, September 7th. Wells Fargo & Company upped their price objective on UiPath from $16.00 to $18.00 and gave the stock an "overweight" rating in a report on Friday, December 2nd. Royal Bank of Canada dropped their price objective on UiPath from $16.00 to $15.00 and set a "sector perform" rating on the stock in a report on Monday, November 28th. JPMorgan Chase & Co. dropped their price objective on UiPath from $18.00 to $16.00 and set a "neutral" rating on the stock in a report on Friday, December 2nd. Finally, Bank of America dropped their price objective on UiPath from $20.00 to $18.00 in a report on Wednesday, September 28th. Nine analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat, UiPath currently has a consensus rating of "Hold" and a consensus price target of $22.23.
About UiPath
(Get Rating)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Further Reading
- Get a free copy of the StockNews.com research report on UiPath (PATH)
- Why You Should Avoid Carvana Even if it Avoids Bankruptcy
- Are Investors Hearing The End Of Spotify's Downtrend?
- The Question of a Fed Pivot Isn't If, It's When, Here's Why
- Top 10 Searched Stocks on MarketBeat All-Access
- 3 Dividend Kings With Royally Good Upside
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
UiPath Inc. (NYSE:PATH ) 首席財務官Ashim Gupta在12月5日(星期一)的交易中出售了10,000股UiPath股票。該股以13.50美元的平均價格出售,總價值為135,000.00美元。交易完成後,首席財務官現在直接擁有該公司1,515,341股,價值約20,457,103.50美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可以通過美國證券交易委員會網站.
阿什姆·古普塔最近還進行了以下交易:
到達UiPath警報:
11月1日,星期二,阿什姆·古普塔出售了10,000股UiPath股票。該股以12.48美元的平均價格出售,總價值為124,800.00美元。
10月3日,星期一,阿什姆·古普塔出售了10,000股UiPath股票。這些股票的平均價格為12.69美元,總價值為126,900.00美元。
9月12日,星期一,阿什姆·古普塔出售了30,000股UiPath股票。這些股票的平均價格為15.02美元,總價值為450,600.00美元。
9月8日,星期四,阿什姆·古普塔出售了10,000股UiPath股票。這些股票的平均價格為13.74美元,總價值為137,400.00美元。
UiPath交易上漲1.0%
Path週四開盤報12.56美元。該業務的50日移動均線切入位為12.27美元,200日移動均線切入位為16.03美元。UiPath Inc.的一年低點為10.40美元,一年高位為48.68美元。
UiPath(NYSE:PATH-GET Rating)最近一次公佈收益結果是在12月1日星期四。這家醫療保健公司公佈了本季度每股收益(0.09美元),比分析師普遍預期的(0.18美元)高出0.09美元。UiPath的淨資產回報率為負17.19%,淨利潤率為負34.99%。該公司本季度營收為2.6274億美元,而市場普遍預期為2.4807億美元。分析師預計,UiPath Inc.將公佈本財年每股收益為0.55美元。
UiPath的機構交易
機構投資者和對衝基金最近改變了他們在該股的頭寸。Dynamic Advisor Solutions LLC在第二季度購買了UiPath的新股份,價值21.2萬美元。北卡羅來納州財政部長在第二季度購買了UiPath的新股份,價值2871,000美元。Alps Advisors Inc.在第二季度購買了價值2,145,000美元的UiPath新股。FDX Advisors Inc.在第二季度將其在UiPath股票的持倉提高了21.8%。FDX Advisors Inc.目前持有這家醫療保健公司21,910股股票,價值399,000美元,此前該公司在上個季度增持了3,924股股票。最後,B.梅茨勒·塞爾。Sohn&Co.AG在第二季度購買了價值22.6萬美元的UiPath新股。51.35%的股票目前由對衝基金和其他機構投資者持有。
華爾街分析師也加入進來
一些研究分析師最近發佈了關於Path股票的報告。在9月7日週三的一份報告中,摩根士丹利將UiPath的評級從增持下調至持平,並將該公司的目標價從32美元下調至15美元。富國銀行將UiPath的目標價從16.00美元上調至18.00美元,並在12月2日星期五的一份報告中給予該股“增持”評級。在11月28日週一的一份報告中,加拿大皇家銀行將UiPath的目標價從16.00美元下調至15.00美元,並對該股設定了“行業表現”評級。摩根大通公司在12月2日星期五的一份報告中將UiPath的目標價從18.00美元下調至16.00美元,並將該股的評級定為“中性”。最後,在9月28日星期三的一份報告中,美國銀行將UiPath的目標價從20.00美元下調至18.00美元。九位分析師對該股的評級為持有,八位分析師對該公司股票的評級為買入。根據MarketBeat的數據,UiPath目前的共識評級為持有,共識目標價為22.23美元。
關於UiPath
(獲取評級)
UiPath Inc.提供端到端自動化平臺,主要在美國、羅馬尼亞和日本提供一系列機器人過程自動化(RPA)解決方案。該公司提供一套相互關聯的軟件來構建、管理、運行、參與、測量和治理組織內的自動化。
進一步閲讀
在UiPath上免費獲取StockNews.com研究報告的副本(路徑)
為什麼你應該避免Carvana,即使它可以避免破產
投資者是否聽到了Spotify下跌趨勢的終結?
美聯儲軸心的問題不是是否,而是何時,這是為什麼
在MarketBeat All-Access上搜索的前10名股票
王室利好的3個股息之王
接收UiPath Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對UiPath和相關公司的最新新聞和分析師評級的每日簡明摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧